adhesence;
care standerdization;
computerized physician orders entry;
deep vein thrombosis prophylaxis;
preventive services;
quality;
improvement;
venous;
thromboembolism;
DEEP-VEIN THROMBOSIS;
ADMISSION ORDER SETS;
ILL MEDICAL PATIENTS;
PROPHYLAXIS;
REGISTRY;
D O I:
10.1002/jhm.562
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
BACKGROUND: Hospital-acquired (HA) venous thromboembolism (VTE) is a common source of morbidity/mortality. Prophylactic measures are underutflized. Available risk assessment models/protocols are not prospectively validated. OBJECTIVES: Improve WE prophylaxis, reduce HA VTE, and prospectively validate a WE risk-assessment model. DESIGN: Observational design. SETTING: Academic medical center. PATIENTS: Adult inpatients on medical/surgical services. INTERVENTIONS: A simple VTE risk assessment linked to a menu of preferred VTE prophylaxis methods, embedded in order sets. Education, audit/feedback, and concurrent identification of nonadherence. MEASUREMENTS: Randomly sampled inpatient audits determined the percent of patients with "adequate" VTE prevention. HA WE cases were identified concurrently via digital imaging system. Interobserver agreement for VTE risk level and judgment of adequate prophylaxis were calculated from 150 random audits. RESULTS: Interobserver agreement with 5 observers was high (kappa score for VTE risk level = 0.81, and for judgment of "adequate" prophylaxis = 0.90). The percent of patients on adequate prophylaxis improved each of the 3 years (58%, 78%, and 93%; P < 0.001) and reached 98% in the last 6 months of 2007; 361 cases of HA VTE occurred over 3 years. Significant reductions for the risk of HA VTE (risk ratio [RR] = 0.69; 95% confidence interval [CI] = 0.47-0.79) and preventable HA VTE (RR = 0.14; 95% CI = 0.06-0.31) occurred. We detected no increase in heparin-induced thrombocytopenia (HIT) or prophylaxis-related bleeding using administrative data/chart review. CONCLUSIONS: We prospectively validated a VTE risk-assessment/prevention protocol by demonstrating ease of use, good interobserver agreement, and effectiveness. Improved VTE prophylaxis resulted in a substantial reduction in HA VTE. Journal of Hospital Medicine 2010;5:10-18. (c) 2010 Society of Hospital Medicine.
机构:
CHOC Childrens Specialists, Div Hematol, 1201 W La Veta Ave, Orange, CA 92868 USACHOC Childrens Specialists, Div Hematol, 1201 W La Veta Ave, Orange, CA 92868 USA
Mahajerin, Arash
Jaffray, Julie
论文数: 0引用数: 0
h-index: 0
机构:
Univ Southern Calif, Keck Sch Med, Childrens Hosp Los Angeles, Div Hematol,Oncol,BMT,Dept Pediat, Los Angeles, CA 90007 USACHOC Childrens Specialists, Div Hematol, 1201 W La Veta Ave, Orange, CA 92868 USA
Jaffray, Julie
Branchford, Brian
论文数: 0引用数: 0
h-index: 0
机构:
Univ Colorado, Dept Pediat, Sch Med, Sect Canc & Blood Disorders, Aurora, CO USA
Childrens Hosp Colorado, Aurora, CO USACHOC Childrens Specialists, Div Hematol, 1201 W La Veta Ave, Orange, CA 92868 USA
Branchford, Brian
Stillings, Amy
论文数: 0引用数: 0
h-index: 0
机构:
Childrens Hosp Los Angeles, Los Angeles, CA 90027 USACHOC Childrens Specialists, Div Hematol, 1201 W La Veta Ave, Orange, CA 92868 USA
Stillings, Amy
Krava, Emily
论文数: 0引用数: 0
h-index: 0
机构:
Childrens Hosp Los Angeles, Los Angeles, CA 90027 USACHOC Childrens Specialists, Div Hematol, 1201 W La Veta Ave, Orange, CA 92868 USA
Krava, Emily
论文数: 引用数:
h-index:
机构:
Young, Guy
Goldenberg, Neil A.
论文数: 0引用数: 0
h-index: 0
机构:
Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
Johns Hopkins Univ, Sch Med, Dept Med Hematol, Baltimore, MD USA
Johns Hopkins All Childrens Hosp, Johns Hopkins All Childrens Inst Clin & Translat, St Petersburg, FL USACHOC Childrens Specialists, Div Hematol, 1201 W La Veta Ave, Orange, CA 92868 USA
Goldenberg, Neil A.
Faustino, E. Vincent S.
论文数: 0引用数: 0
h-index: 0
机构:
Yale Sch Med, Pediat Crit Care Sect, Dept Pediat, New Haven, CT USACHOC Childrens Specialists, Div Hematol, 1201 W La Veta Ave, Orange, CA 92868 USA